When a family chooses a hospital, what wins — the name, the doctor, or the drive?
A major US health system had retired two trusted legacy brands under one new name. Standard brand tracking measures levels — awareness, favorability. This instrument measured weight: the share of the actual decision each force carries, from forced trade-offs on an 800-persona, census-anchored synthetic panel across the system's two regional markets.
The name is a tiebreaker, never a driver. Physicians and insurance networks carry the choice — which makes the few moments where the name does convert the entire brand strategy.
The sunset dial: one legacy brand transferred. The other refused.
The cleanest test in the study: two hospitals identical in every way — same doctors, distance, wait, network — differing only in the name on the building. The share who still walk into the retired name is the "sunset dial," readable quarterly. The two regions returned opposite answers:
REGION A · LEGACY BRAND A
49.5%
choose the legacy name on identical hospitals — a coin flip. Equity has transferred; the "formerly …" bridge has done its work.
REGION B · LEGACY BRAND B
87.5%
still walk into the retired name, four years after it officially ceased to exist — a 7-to-1 preference. The bridge is still load-bearing.
n=400 PER REGION · IDENTICAL-HOSPITAL FORCED TRADE-OFF · THE DIAL DECIDES WHEN TO RETIRE THE BRIDGE — BY EVIDENCE, NOT AGENCY TIMELINE
What actually carries the decision
PHYSICIAN
INSURANCE NETWORK
DISTANCE & WAIT
THE NAME
RELATIVE DECISION WEIGHT, ILLUSTRATIVE SCALE — EXACT SHARES VARY BY DECISION TYPE AND REGION. A FORCE'S WEIGHT IS ITS PULL WHEN THAT FACTOR DIFFERS BETWEEN OPTIONS. THE NAME'S CEILING: 11% OF ANY DECISION, AT THE "IF IT'S SERIOUS" MOMENT.
Three findings a tracker would never surface
FINDING 01
Every decision type is physician-led — the question is degree, and it splits by region. In one region the name carried 3% of the cardiology choice; in the other, 9% — a legacy-brand halo that means one marketing playbook cannot serve both regions.
FINDING 02
Stated versus revealed: asked directly, 67% claim the insurance network decides for them. Their actual trade-offs show the answer depends on the decision. The gap between what people say drives them and what measurably does is itself a finding — and a media-planning input.
FINDING 03
The name converts in exactly three places — a specific service line in one region (where it beat the named competitor 2-to-1 among deciders), the severity leap ("if it's serious"), and the sunset decision itself. Everything else is physician-first or operations-first spend.
From signal to plan
Each finding cascades into a play with a measured baseline and a tracking mechanism: concentrate brand-led creative where the name demonstrably converts; hold the second region's "formerly …" bridge and retire it by evidence, not timeline; shift the halo service line to physician-first creative. A quarterly re-run of the same panel — same instrument, same segments — reports the delta on every baseline.
Synthetic respondents, real discipline
800 PERSONAS · ACS CENSUS MICRODATA, OFFICIAL WEIGHTS32,975 FORCED TRADE-OFF RESPONSES · ZERO PARSE FAILURESFICTIONAL-BRAND CONTROL ARMCROSS-MODEL SHADOW RUN — ORDERINGS HOLDCALIBRATION ANCHORS PUBLISHED, MISSES INCLUDEDZERO PHI — NO PATIENT RECORDS, EVER
Panel marginals hit census targets; known biases (position preference, engagement over-report) are measured and absorbed in estimation, not hidden. Orderings, gaps, and region differences are the claims; absolute percentages are directional. Accuracy of the underlying instruments is validated against real-world outcomes.
CLIENT AND MARKET UNNAMED · SELF-INITIATED STUDY · METHODOLOGY AND STRUCTURAL FINDINGS PUBLISHED WITH NO CLIENT DATA · ADVISORSPRINT ENGAGEMENTS ARE CONFIDENTIAL BY DEFAULT
Map a decision you're about to bet on.
A rebrand, a launch, a committee sale — before the budget commits, know which force decides.